𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II study of every other day high-dose ifosfamide in pediatric brain tumors

✍ Scribed by Richard L. Heideman; Edwin C. Douglass; James A. Langston; Jeffrey P. Krischer; Peter C. Burger; Edward H. Kovnar; Larry E. Kun; Henry S. Friedman; Richard Kadota


Publisher
Springer US
Year
1995
Tongue
English
Weight
683 KB
Volume
25
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase II study of ifosfamide in childhoo
✍ Chastagner, Pascal ;Sommelet-Olive, DaniΓ¨le ;Kalifa, Chantal ;Brunat-Mentigny, M πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 482 KB

## Abstract Forty‐two evaluable pediatric patients with a variety of recurrent primary brain tumors participated in a phase II ifosfamide trial. Their mean age was 10 years. All patients were treated with ifosfamide, 3 g/m^2^/day for 2 days every 2 weeks. Response was assessed on clinical and radio

Ifosfamide/etoposide combination in the
✍ Faith H. Kung; Charles B. Pratt; Roger A. Vega; Norman Jaffe; Douglas Strother; πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 509 KB

Background. The prognosis for children with recurrent or resistant malignant solid tumors remains dismal. More effective rescue therapy is needed for these children. Methods. Between August 1987 and November 1990, 311 children with recurrent or resistant malignant solid tumors were treated by inves

Activity of postoperative carboplatin, e
✍ Kellie, Stewart J. ;Wong, Christopher K.F. ;Pozza, Luciano Dalla ;Waters, Keith πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 89 KB

## Background: Chemotherapy is used as an alternative to irradiation or to minimize the irradiation exposure among infants with medulloblastoma or other cns embryonal tumors. adjuvant chemotherapy is commonly used in older children with high-risk medulloblastoma to improve survival or to allow a re